Section Arrow
Quote
COLL.NASDAQ
- Collegium Pharmaceutical
Quotes are at least 15-min delayed:2026/02/10 05:55 EST
Pre Market
Last
 --
-- (--)
Bid
18.52
Ask
50.9
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 46.28
-1.33 (-2.79%)
Day High 
47.525 
Prev. Close
47.61 
1-M High
49.31 
Volume 
211.00K 
Bid
18.52
Ask
50.9
Day Low
46.035 
Open
47.34 
1-M Low
43.615 
Market Cap 
1.50B 
Currency 美元 
P/E 28.39 
%Yield -- 
10-SMA 46.46 
20-SMA 46.6 
50-SMA 47.34 
52-W High 50.7866 
52-W Low 23.23 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.63/6.06
Enterprise Value
2.30B
Balance Sheet
Book Value Per Share
8.69
Cash Flow
Cash Flow Yield
0.15
Income Statement
Total Revenue
631.45M
Operating Revenue Per Share
17.29
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health19.33-3.69-16.03%36.28PE
Pre Market 18.8 -0.53 -2.74%
VTRSViatris15.56+0.98+6.72%227.2PE
Pre Market 15.59 +0.03 +0.19%
BFRIBiofrontera0.8103-0.0107-1.30%0.74PE
Pre Market 0.7424 -0.0679 -8.38%
CGCCanopy Growth Corp1.09-0.01-0.91%-- 
Pre Market 1.11 +0.02 +1.83%
HLNHaleon plc10.88-0.1-0.91%23.79PE
Pre Market 10.85 -0.03 -0.28%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.